BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 93151)

  • 1. [Clinical evaluation of tumor scintigraphy with 99mTc-bleomycin. (Part II). Combined studies of tumor scintigraphy with 99mTc-BLM and 67Ga-citrate, bone scintigraphy and angiography in bone and soft tissue tumors (author's transl)].
    Odori T
    Kaku Igaku; 1979 Sep; 16(6):829-47. PubMed ID: 93151
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bone scintigraphy--abnormal RI accumulation in soft tissue metastasis from osteosarcoma with 99Tc-MDP (author's transl)].
    Suzuki M; Kato T; Imaeda T; Doi H
    Rinsho Hoshasen; 1979 Jan; 24(1):171-2. PubMed ID: 283256
    [No Abstract]   [Full Text] [Related]  

  • 3. Scintigraphy with 99mTc-phosphonate and 67gallium in patients suspected of primary bone tumors.
    Edeling CJ
    Nuklearmedizin; 1982 Aug; 21(4):136-9. PubMed ID: 6959075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of bone scintigraphy with 99mTc-labeled phosphate compounds. (II). Primary bone tumor and tumor-like lesion (author's transl)].
    Yamamoto I
    Kaku Igaku; 1978 Oct; 15(7):969-79. PubMed ID: 283257
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.
    Taki J; Sumiya H; Tsuchiya H; Tomita K; Nonomura A; Tonami N
    J Nucl Med; 1997 Apr; 38(4):501-6. PubMed ID: 9098190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of 99mTc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy: comparison with 99mTc-MDP (author's transl)].
    Honda H; Oshiumi Y; Kamoi I; Ichiya Y; Wada M; Matsuura K
    Kaku Igaku; 1981 Nov; 18(9):1315-9. PubMed ID: 6461790
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of bone scintigraphy in differential diagnosis of benign bone tumors].
    Okuyama T; Suzuki H; Nakamoto K; Suzuki S
    Kaku Igaku; 1982 Dec; 19(10):1519-30. PubMed ID: 6302357
    [No Abstract]   [Full Text] [Related]  

  • 8. [Observation on 99mTc-diphosphonate scintigram in soft part tumors adjacent to bone (author's transl)].
    Okuyama T; Suzuki H; Shibuya H; Suzuki S; Kawaguchi N; Amino K
    Kaku Igaku; 1978 Jun; 15(4):569-76. PubMed ID: 702933
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical value of bone and gallium scintigraphy for soft-tissue sarcomas of the extremities.
    Kirchner PT; Simon MA
    J Bone Joint Surg Am; 1984 Mar; 66(3):319-27. PubMed ID: 6230363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of bone scintigraphy with 99mTc-labeled phosphate compounds. I. Metastatic bone tumor (author's transl].
    Yamamoto I
    Nihon Igaku Hoshasen Gakkai Zasshi; 1978 Sep; 38(9):862-78. PubMed ID: 101970
    [No Abstract]   [Full Text] [Related]  

  • 11. Scintigraphic evaluation of childhood malignancies by 67Ga-citrate.
    Bekerman C; Port RB; Pang E; Moohr JW; Kranzler JK
    Radiology; 1978 Jun; 127(3):719-25. PubMed ID: 663163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluations of clinical usefulness of bone and tumor scintigraphy in neuroblastomas: detection of extraosseous lesions (author's transl)].
    Miyoshi M; Oshiumi Y; Kamoi I; Ichiya Y; Nishitani H; Matsuura K; Jo K; Ono Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1980 May; 40(5):458-65. PubMed ID: 7422473
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bone scintigraphy with 99mTc-pyrophosphate in the diagnosis of the degree of the spread of the tumor process in the head and neck area].
    Prikhod'ko AG
    Med Radiol (Mosk); 1982 Jan; 27(1):58-67. PubMed ID: 6276643
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evaluation of bone metastases from carcinoma of the prostate by bone scintigraphy with 99mTc-phosphorous compounds (author's transl)].
    Bussaka H; Fujimura N; Yamasaki K
    Kaku Igaku; 1980 Apr; 17(3):297-303. PubMed ID: 7392308
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of lung metastases from osteosarcoma by scintigraphy using 99mTc-methylene diphosphonate.
    Hoefnagel CA; Bruning PF; Cohen P; Marcuse HR; van der Schoot JB
    Diagn Imaging; 1981; 50(5):277-84. PubMed ID: 6457735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.
    Taki J; Sumiya H; Asada N; Ueda Y; Tsuchiya H; Tonami N
    J Nucl Med; 1998 Jul; 39(7):1179-84. PubMed ID: 9669390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study on bone metastases from bronchogenic carcinoma by bone scintigraphy with 99mTc-phosphorous compounds. III. The ability of detection by bone scintigraphy and roentgenography in bone destructed by Pancoast's tumor (author's transl)].
    Fujimura N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1979 Sep; 39(9):984-92. PubMed ID: 514803
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bone metastases from breast cancer as detected by bone scintigraphy with 99mTc-phosphorous compounds (author's transl)].
    Fujimura N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1978 May; 38(5):449-56. PubMed ID: 693261
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical use of 99mTc-methylene diphosphonate (MDP) as bone imaging agent (author's transl)].
    Senda K; Imaeda T; Kato T; Asada S; Doi H
    Rinsho Hoshasen; 1978 Sep; 23(9):937-42. PubMed ID: 691805
    [No Abstract]   [Full Text] [Related]  

  • 20. [A case report of reticulum cell sarcoma with abnormal accumulation of 67Ga-citrate and 99mTc-MDP (author's transl)].
    Wada S; Kamoi I; Matsuura K
    Rinsho Hoshasen; 1978 Jul; 23(7):803-4. PubMed ID: 353334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.